NCT05663684View on ClinicalTrials.gov

Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?

PHASE4RecruitingINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

January 31, 2023

Conditions
EpiphoraDacryostenosisDacryocystitis
Interventions
DRUG

Proparacaine Hydrochloride ophthalmic solution, USP 0.5%

One drop instilled in one eye, randomly chosen, as topical anesthetic

DRUG

Balanced salt solution

One drop instilled in one eye, randomly chosen, as control placebo

Trial Locations (1)

70112

RECRUITING

Louisiana State University Health Sciences Center, New Orleans

All Listed Sponsors
lead

Louisiana State University Health Sciences Center in New Orleans

OTHER